{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:56:03Z","timestamp":1790657763546,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","award":["the EPIFARM-Pharmaco-epidemiology Agreement"],"award-info":[{"award-number":["the EPIFARM-Pharmaco-epidemiology Agreement"]}],"id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12325-026-03685-2","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:58:45Z","timestamp":1784185125000},"page":"4633-4645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of the COVID-19 Pandemic on Adherence and Persistence to Glaucoma Therapy: A Retrospective Italian Cohort Study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0163-1034","authenticated-orcid":false,"given":"Alessia Antonella","family":"Galbussera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-0887","authenticated-orcid":false,"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6006-0376","authenticated-orcid":false,"given":"Ida","family":"Fortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-0572","authenticated-orcid":false,"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-1713","authenticated-orcid":false,"given":"Luciano","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"11","key":"3685_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013.","journal-title":"Ophthalmology"},{"issue":"7","key":"3685_CR2","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence. Ophthalmology. 2015;122(7):1308\u201316. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.026.","journal-title":"Ophthalmology"},{"issue":"4","key":"3685_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ophtha.2006.09.025","volume":"114","author":"GF Schwartz","year":"2007","unstructured":"Schwartz GF, Platt R, Reardon G, Mychaskiw MA. Accounting for restart rates in evaluating persistence with ocular hypotensives. Ophthalmology. 2007;114(4):648\u201352. https:\/\/doi.org\/10.1016\/j.ophtha.2006.09.025.","journal-title":"Ophthalmology"},{"issue":"11","key":"3685_CR4","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1167\/iovs.07-0290","volume":"48","author":"DS Friedman","year":"2007","unstructured":"Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052. https:\/\/doi.org\/10.1167\/iovs.07-0290.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3685_CR5","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s40123-023-00730-z","volume":"12","author":"L Quaranta","year":"2023","unstructured":"Quaranta L, Novella A, Tettamanti M, Pasina L, Weinreb RN, Nobili A. Adherence and persistence to medical therapy in glaucoma: an overview. Ophthalmol Ther. 2023;12(5):2227\u201340. https:\/\/doi.org\/10.1007\/s40123-023-00730-z.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"3685_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/11206721211002442","volume":"32","author":"R dell\u2019 Omo","year":"2022","unstructured":"dell\u2019Omo R, Filippelli M, Virgili G, et al. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: a report from 39 institutional centers. Eur J Ophthalmol. 2022;32(1):695\u2013703. https:\/\/doi.org\/10.1177\/11206721211002442.","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"3685_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/02713683.2020.1752737","volume":"45","author":"MR Romano","year":"2020","unstructured":"Romano MR, Montericcio A, Montalbano C, et al. Facing COVID-19 in ophthalmology department. Curr Eye Res. 2020;45(6):653\u20138. https:\/\/doi.org\/10.1080\/02713683.2020.1752737.","journal-title":"Curr Eye Res"},{"issue":"3","key":"3685_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ophtha.2021.10.009","volume":"129","author":"L Racette","year":"2022","unstructured":"Racette L, Abu SL, Poleon S, Thomas T, Sabbagh N, Girkin CA. The impact of the coronavirus disease 2019 pandemic on adherence to ocular hypotensive medication in patients with primary open-angle glaucoma. Ophthalmology. 2022;129(3):258\u201366. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.009.","journal-title":"Ophthalmology"},{"issue":"1","key":"3685_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1056\/NEJMc2009166","volume":"383","author":"O De Filippo","year":"2020","unstructured":"De Filippo O, D\u2019Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 2020;383(1):88\u20139. https:\/\/doi.org\/10.1056\/NEJMc2009166.","journal-title":"N Engl J Med"},{"issue":"7","key":"3685_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/17425247.2023.2219053","volume":"20","author":"ZK Al-Qaysi","year":"2023","unstructured":"Al-Qaysi ZK, Beadham IG, Schwikkard SL, Bear JC, Al-Kinani AA, Alany RG. Sustained release ocular drug delivery systems for glaucoma therapy. Expert Opin Drug Deliv. 2023;20(7):905\u201319. https:\/\/doi.org\/10.1080\/17425247.2023.2219053.","journal-title":"Expert Opin Drug Deliv"},{"issue":"10","key":"3685_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103317","volume":"14","author":"J Jesus","year":"2025","unstructured":"Jesus J, Aguiar C, Meira D, Rodriguez-Una I, Beir\u00e3o JM. Telemonitoring tools for glaucoma patients: a systematic review of current trends and applications. JCM. 2025;14(10):3317. https:\/\/doi.org\/10.3390\/jcm14103317.","journal-title":"JCM"},{"key":"3685_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/OPTH.S450629","volume":"18","author":"J Choi","year":"2024","unstructured":"Choi J, Amin P, Tarantino A, Qiu M. Improved glaucoma medication access through pharmacy partnership: a single institution experience. OPTH. 2024;18:981\u20137. https:\/\/doi.org\/10.2147\/OPTH.S450629.","journal-title":"OPTH"},{"issue":"2","key":"3685_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2025.09.023","volume":"133","author":"G Montesano","year":"2026","unstructured":"Montesano G, Crabb DP, Garway-Heath DF, et al. Six-year rate of visual field progression in the laser in glaucoma and ocular hypertension trial. Ophthalmology. 2026;133(2):169\u201377. https:\/\/doi.org\/10.1016\/j.ophtha.2025.09.023.","journal-title":"Ophthalmology"},{"issue":"1","key":"3685_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/IJG.0000000000002256","volume":"33","author":"A Sharma","year":"2024","unstructured":"Sharma A, Roh S, Ramsey DJ. Targeted telephone-based outreach reconnects glaucoma patients with subspecialty care. J Glaucoma. 2024;33(1):28\u201334. https:\/\/doi.org\/10.1097\/IJG.0000000000002256.","journal-title":"J Glaucoma"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03685-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03685-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:14:56Z","timestamp":1790655296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03685-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03685-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alessia Antonella Galbussera has nothing to disclose. Mauro Tettamanti has nothing to disclose. Ida Fortino has nothing to disclose. Alessandro Nobili has nothing to disclose. Luciano Quaranta is an Editorial Board member of\n                      Advances in Therapy\n                      . Luciano Quaranta was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Luciano Quaranta has nothing else to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with the Declaration of Helsinki. The study was exempt from patients' informed consent, and this requirement was waived according to the General Authorization for the Processing of Personal Data for Scientific Research Purposes issued by the Italian Privacy Authority on August 10, 2018 (\n                      \n                      ). Furthermore, the study provided sufficient guarantees of individual records anonymity, with respect to Italian privacy law.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}